Brief: Dynavax Technologies Q3 Net Income USD 14.293 Million
02/11/2023 20:01
Nov 02 (Reuters) - Dynavax Technologies Q3 pretax profit USD 14.146 million. * Q3 operating expenses USD 64.398 million * Q3 product revenues USD 62,318,000 million * Q3 operating income USD 5.116 million
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality